Neuroectodermal Tumors  >>  crenolanib (ARO-002)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
crenolanib (ARO-002) / AROG
NCT01393912: PDGFR Inhibitor Crenolanib in Children/Young Adults With Diffuse Intrinsic Pontine Glioma or Recurrent High-Grade Glioma

Completed
1
55
US
Crenolanib, CP-868,596
St. Jude Children's Research Hospital, Arog Pharmaceuticals, Inc., The V Foundation for Cancer Research
Diffuse Intrinsic Pontine Glioma, Progressive or Refractory High-Grade Glioma
09/14
10/16

Download Options